Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.
Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US14070B3096
Filter zurücksetzen
Do you already know our new terminal view? Click here.
FIGI: BBG000DZMK99
CAPR
Capricor Therapeutics, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Capricor Therapeutics, Inc.
ISIN
US14070B3096
TICKER
CAPR
MIC
XNAS
REUTERS
CAPR.OQ
BLOOMBERG
CAPR US
Fr., 28.08.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - August 28, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through July...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 28.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 28.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 27, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 27.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 27, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 27.08.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - August 27, 2026) - National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company i...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 27.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 26, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 27.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 26.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 26, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 26.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Capricor to Contact Him Directly to Discuss Their OptionsNew York, New York--(Newsfile Corp. - August 26, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors of the September 28, 2026 deadlin...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 25.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Di., 25.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 25, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 25.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 24.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 24.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 24, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 24.08.2026       Capricor Therapeutics
US14070B3096

– New PDUFA target action date of November 22, 2026 follows submission of additional Phase 3 HOPE-3 data and analyses supporting a refined proposed indication –...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 23.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 23.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 22.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 22.08.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - August 21, 2026) - National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call—notable for an omission of management Q&A with analysts—the company i...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 21.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 21, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Silent Ad
Fr., 21.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 21, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 21.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 20.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 20, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 20.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 19, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - August 19, 2026) - National investor rights law firm Hagens Berman highlights developments surrounding Capricor Therapeutics, Inc. (NASDAQ: CAPR). Following Capricor's recent Q2 2026 earnings release and conference call-notable for an omission of management Q&A with analysts-the company is facing unc...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the pa...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 19.08.2026       Capricor Therapeutics
US14070B3096

If you have suffered a loss on your Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NASDAQ: CAPR) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.Investors have un...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 18.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 18.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 18, 2026) - Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) between December 17, 2025 and July 6, 2026,...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Di., 18.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 18, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 17.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 17.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 17.08.2026       Capricor Therapeutics
US14070B3096

Philadelphia, Pennsylvania--(Newsfile Corp. - August 17, 2026) - National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) ("Capricor" or the "Company") on behalf of investors who purchased or acquired Capricor securities during the period from December 17, 2025 through July...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mo., 17.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 17, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 16.08.2026       Capricor Therapeutics
US14070B3096

San Diego, California--(Newsfile Corp. - August 16, 2026) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), have until Monday, September 28, 2026 to seek appointment as lead plaintiff of t...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
So., 16.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Sa., 15.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 15, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you purch...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 14.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 14, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 14.08.2026       Capricor Therapeutics
US14070B3096

Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Capricor Therapeutics, Inc. (Capricor) (NASDAQ: CAPR) on behalf of those who purchased or acquired Capricor securities between December 17, 2025 and Jul...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 14.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Fr., 14.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 14, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Capricor Therapeutics
US14070B3096

San Francisco, California--(Newsfile Corp. - August 13, 2026) - Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now.A securities fraud class action lawsuit has been filed against Capricor, and investors are encouraged to contact the firm regarding potential recov...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Capricor Therapeutics
US14070B3096

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - August 13, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit.CLASS DEFINITION: The...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Do., 13.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 13, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) on behalf of investors that purchased or otherwise acquired Capricor securities between December 17, 2025 and July 26, 2026 (th...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 12.08.2026       Capricor Therapeutics
US14070B3096

New York, New York--(Newsfile Corp. - August 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline.SO WHAT: If you...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink
Mi., 12.08.2026       Capricor Therapeutics
US14070B3096

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Capricor between December 17, 2025 and July 26, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner...
Zur Nachricht
Capricor Therapeutics
Charts & Research Termsheets Terminal
Permalink